Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this double-blind, placebo controlled study is to evaluate the safety and
effectiveness of an investigational Parkinson's disease drug in patients with advanced
disease who are not well-controlled on their L-dopa medication.